Pet Microchips MarketSize, Share & Industry Analysis, 2026-2034By TypeBy ApplicationBy End UserBy Distribution ChannelBy Functionality
Full title & scope — all 5 axes with their segments
Pet Microchips Market Size, Share & Industry Analysis, By Type (125 kHz Microchip, 128 kHz Microchip, 134.2 kHz Microchip), By Application (Dogs, Cats, Horse, Others), By End User (Veterinary Clinics & Hospitals, Animal Shelters & Rescue Organizations, Breeders & Catteries/Kennels), By Distribution Channel (Direct Sales, Distributors & Wholesalers, E-commerce/Online), By Functionality (Standard Identification Microchips, Bio-Sensor Enabled (Temperature-Sensing) Microchips), and Regional Forecast, 2026-2034
Market outlook, key takeaways, drivers and challenges for the report period.
- 01By Type125 kHz Microchip · 128 kHz Microchip · 134.2 kHz Microchip
- 02By ApplicationDogs · Cats · Horse
- 03By End UserVeterinary Clinics & Hospitals · Animal Shelters & Rescue Organizations · Breeders & Catteries/Kennels
- 04By Distribution ChannelDirect Sales · Distributors & Wholesalers · E-commerce/Online
- 05By FunctionalityStandard Identification Microchips · Bio-Sensor Enabled
- 06By Region
Market Analysis & Outlook
A pet microchip is a small implantable radio-frequency identification transponder, typically inserted beneath the skin between the shoulder blades of a dog, cat or horse, that stores a unique identification number retrievable by a compatible scanner. The category includes the transponder itself along with the injector needles used for implantation and the handheld or fixed scanners used to read the stored number, and it is purchased primarily by veterinary clinics, animal shelters and rescue organizations, and breeders on behalf of the animals in their care. Buyers value the product for permanent, tamper-resistant identification that supports lost-pet recovery, ownership disputes, and compliance with jurisdictions that require proof of identification for licensing, adoption or cross-border travel.
Between 2025 and 2034 the global pet microchips market moves from USD 612.6 million to USD 1191.8 million, compounding at 7.7% a year. Fifteen years are covered in all, taking in USD 390 million in 2020, USD 559.7 million in 2024, USD 658.5 million in 2026 and USD 885.9 million in 2030.
On the type axis, growth rates run from 4.04% for 125 kHz Microchip up to 9.15% for 134.2 kHz Microchip. 134.2 kHz Microchip carries the volume: USD 379.8 million and 62% of revenue in 2025, USD 834.3 million and 70% in 2034. Share moves toward 134.2 kHz Microchip and away from 125 kHz Microchip and 128 kHz Microchip, though no line shrinks in revenue terms.
The application split puts Dogs first, at USD 318.5 million and 52% of revenue in 2025, rising to USD 595.9 million and 50% in 2034. Cats grows faster at 9.05% against 7.21%, moving from 33% of revenue to 37% by 2034. It cuts the same total as the type axis from a different commercial angle, so revenue does not add across the two.
The regional order runs from North America at 38% of 2025 revenue down to Middle East and Africa at 4%. North America is worth USD 232.8 million in 2025 and USD 405.2 million in 2034; Europe, second at 32%, moves from USD 196 million to USD 345.6 million. Because Asia Pacific and Latin America take share, the revenue added by 2034 concentrates instead of spreading across all five regions.
Behind these figures sit five regions, three type lines and five segmentation axes, each reported for every year from 2020 to 2034. The headline 2025 value is triangulated from published sources and category proxies, with no independently sourced count behind it, and the same applies to the segment, regional and country breakdowns drawn from it.
Market Size, 2020–2034
USD MillionRevenue in USD Million. Values up to 2025 are actuals; 2026–2034 are forecast.
Key Takeaways
- The global pet microchips market moves from USD 390 million in 2020 to USD 612.6 million in 2025 and USD 1191.8 million by 2034, the forecast period compounding at 7.7% a year.
- The largest line by type is 134.2 kHz Microchip, worth USD 379.8 million and 62% of revenue in 2025, rising to USD 834.3 million and 70% by 2034.
- Scenario range for 2034 runs from USD 1072.6 million in the bear case to USD 1311 million in the bull case, against a base-case USD 1191.8 million, the spread a plan built on this forecast has to absorb.
- 38% of 2025 revenue is generated in North America, worth USD 232.8 million and rising to USD 405.2 million by 2034; Middle East and Africa is smallest at 4%.
- 85.01% of North America's base-year revenue comes from the United States alone: USD 197.9 million in 2025, rising to USD 344.4 million by 2034, which is why it is that region's worked example.
- Every line on all five segmentation axes and in each of the five regions carries its own revenue, share and growth rate for all fifteen years, 2020 through 2034, on a 2025 base.
Market Trends
Revenue Share, By By Type
Base year 2025134.2 kHz Microchip leads with 62.0% of by type segment revenue.
Share of by type segment revenue, most recent base year.
The global pet microchips market is shaped over 2026-2034 by three measurable movements: a change in the type mix, a shift in where revenue sits geographically, and the 7.7% rate carrying the total.
All three are changes in mix, not in direction: nothing contracts, and the movement is in which lines and regions absorb the new revenue.
The type mix tilts toward 134.2 kHz Microchip. The widest spread on the type axis is between 134.2 kHz Microchip at 9.15% and 125 kHz Microchip at 4.04%. Over the forecast period that moves 134.2 kHz Microchip from 62% of revenue to 70%, and 125 kHz Microchip from 15% to 11%. In absolute terms 134.2 kHz Microchip rises from USD 379.8 million to USD 834.3 million, while 125 kHz Microchip rises from USD 91.9 million to USD 131.1 million. Both grow; the gap is wide enough to reshape the mix inside a single forecast window.
Growth concentrates in Asia Pacific and Latin America. Asia Pacific moves from 20% of revenue in 2025 to 26% in 2034, worth USD 122.5 million rising to USD 309.9 million; Latin America moves from 6% of revenue in 2025 to 7% in 2034, worth USD 36.8 million rising to USD 83.4 million. Against that, North America at 38% moving to 34%, Europe at 32% moving to 29%, Middle East and Africa at 4% moving to 4%, a fall in share, not in revenue. That makes the regional split worth reading directly instead of scaling from the global rate: the same market rate produces different outcomes depending on where a supplier's revenue sits.
A continuation, not an inflection. Fifteen years of revenue run USD 390 million in 2020, USD 559.7 million in 2024, USD 612.6 million in 2025, USD 658.5 million in 2026, USD 885.9 million in 2030 and USD 1191.8 million in 2034. No year breaks the trajectory, and the 7.7% forecast rate compares with 9.46% recorded over 2020-2025, a continuation, not an inflection. That moves the planning question away from timing a turn and onto the type and regional mixes, where the actual movement is.
Market Growth Factors
Growth is concentrated in 134.2 kHz Microchip
Market Drivers
3- 01Growth is concentrated in 134.2 kHz Microchip
At 9.15% against a market rate of 7.7%, 134.2 kHz Microchip is the line pulling the average up: USD 379.8 million to USD 834.3 million, and 62% of revenue to 70%. Because the spread to 125 kHz Microchip at 4.04% is this wide, the headline 7.7% is a weighted result, not a rate any single line achieves. Where a supplier sits on this axis therefore decides whether it grows with the market or below it.
- 02The two largest regions hold most of the base
North America is the largest region at USD 232.8 million in 2025, 38% of global revenue, and reaches USD 405.2 million by 2034 while holding 34%. Europe adds a further 32% at USD 196 million, reaching USD 345.6 million. Most of the base and most of the growth sit in those two, and a plan spread evenly across regions therefore over-invests outside them.
- 03The base has grown every year since 2020
USD 390 million in 2020, USD 559.7 million in 2024 and USD 612.6 million in 2025: 9.46% compound growth before the forecast period even begins. From there the forecast carries 7.7% through to USD 1191.8 million in 2034. With the trajectory already demonstrated over fifteen years, what remains uncertain is the mix, not the direction, which is where the segment and regional sections do the work.
Growth drivers
| # | Growth driver | Impact | Gross contribution (Million) | 2026-28 | 2029-31 | 2032-34 |
|---|---|---|---|---|---|---|
| 1 | Government-Mandated Pet Identification Programs | High | +190 | High | Medium | Medium |
| 2 | Rising Global Pet Ownership and Humanization Trends | High | +170 | High | High | Medium |
| 3 | Expansion of Animal Shelter and Rescue Adoption Programs | Medium-High | +110 | Medium | High | High |
| 4 | Increasing Veterinary Visit Frequency and Preventive Care Adoption | Medium | +80 | Medium | Medium | Medium |
| 5 | Adoption of ISO-Standard Universal Scanning Infrastructure | Medium | +60 | High | Medium | Low |
| 6 | Others | Low | +40 | Low | Low | Low |
| Total | +650 | |||||
Restraints
| # | Restraint | Impact | Estimated reduction (Million) | 2026-28 | 2029-31 | 2032-34 |
|---|---|---|---|---|---|---|
| 1 | Cost Sensitivity Among Pet Owners in Emerging Markets | Medium | −40 | Medium | Medium | Low |
| 2 | Availability of Low-Cost Unregistered or Counterfeit Chips | Low | −20 | Low | Low | Low |
| 3 | Data Privacy and Registry Fragmentation Concerns | Low | −10.8 | Low | Low | Low |
| Total | −70.8 | |||||
Drivers contribute 650 Million and restraints remove 70.8 Million, a net 579.2 Million, which is the revenue the market adds between the base year and 2034. Contributions are CDI estimates, apportioned so that they reconcile with the forecast rather than being read from it.
The 7.7% forecast rate rests on three things that can be measured separately: the size of the existing base, the mix shift on the type axis, and where regional growth is concentrated.
Restraining Factors
What holds the forecast back
Market Restraints
2- 01What holds the forecast back
A bear case of USD 1072.6 million in 2034, against USD 1191.8 million in the base case, rests on one stated assumption: planned mandate expansions are delayed or scaled back in one or more major markets, and shelter funding constraints slow bulk implantation programs. Neither case changes the USD 612.6 million 2025 base.
- 02128 kHz Microchip grows below the market rate
With 23% of 2025 revenue (USD 140.9 million) 128 kHz Microchip is where most of the market sits, and it grows at only 5.39% against the market's 7.7%. Revenue still reaches USD 226.4 million by 2034 and share still falls to 19%: a drag on the average, not a decline.
Market Opportunities
Where the forecast could be beaten
Market Opportunities
2- 01Where the forecast could be beaten
The upside path assumes mandatory microchipping laws are adopted in additional jurisdictions faster than currently legislated, and shelter and rescue programs receive expanded public funding that accelerates bulk implantation. It ends 2034 at USD 1311 million against a USD 1191.8 million base case, off the same USD 612.6 million base year.
- 02The opening is on the type axis, not the regional one
Share on the type axis moves toward 134.2 kHz Microchip, from 62% in 2025 to 70% in 2034, on 9.15% growth against the market's 7.7% and revenue rising from USD 379.8 million to USD 834.3 million. Taking position there does not require displacing whoever holds 134.2 kHz Microchip, which is the harder and more expensive fight.
Market Challenges
Revenue is concentrated in 134.2 kHz Microchip
Market Challenges
2- 01Revenue is concentrated in 134.2 kHz Microchip
One line dominates: 134.2 kHz Microchip, at 62% of revenue in 2025 and 70% in 2034, worth USD 379.8 million and USD 834.3 million. That concentration means the market's own forecast is, to a large extent, a forecast for one type line.
- 02The United States is 85.01% of North America
The United States generates USD 197.9 million of North America's USD 232.8 million in 2025, 85.01% of the region, reaching USD 344.4 million by 2034. Regional totals therefore move largely with one country's demand, so a regional forecast is more exposed to single-country conditions than its size alone suggests.
Segmentation Analysis
5 axesfive segmentation axes are reported; by type, by application, end user, distribution channel and functionality. They are alternative readings of one revenue pool, not parts that sum to it.
There are three lines on the type axis, and all of them grow in revenue between 2025 and 2034. What separates them is share: one gains it, the rest give it up.
By Type · 3 segments
134.2 kHz Microchip Holds the Largest Type Share and Is Still the Quickest to Grow
- Largest 134.2 kHz Microchip · 62%
- Fastest 134.2 kHz Microchip · 9.2%
- Moves most 134.2 kHz Microchip · +8 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| 125 kHz Microchip | $91.90M | 15% | $131M | 11%-4 | 4% |
| 128 kHz Microchip | $141M | 23% | $226M | 19%-4 | 5.4% |
| 134.2 kHz Microchip | $380M | 62% | $834M | 70%+8 | 9.2% |
134.2 kHz leads and is growing fastest because it is the ISO-standard frequency accepted internationally, letting a single chip be read by universal scanners across borders and satisfying import and travel documentation requirements. 125 kHz and 128 kHz chips persist mainly in older United States installations where legacy scanners remain in service, but are gradually being phased out as clinics upgrade to universal readers. 134.2 kHz Microchip remains the largest line through 2034, so the axis changes in proportion, not in order. This is the axis the estimation prices in full, year by year, and the one the regional chapters cut against.
By Application · 4 segments
Cats Outpaces the Axis While Dogs Holds the Largest Share
- Largest Dogs · 52%
- Fastest Cats · 9.1%
- Moves most Cats · +4 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Dogs | $319M | 52% | $596M | 50%-2 | 7.2% |
| Cats | $202M | 33% | $441M | 37%+4 | 9.1% |
| Horse | $49M | 8% | $83.40M | 7%-1 | 6.1% |
| Others | $42.90M | 7% | $71.50M | 6%-1 | 5.8% |
Dogs lead because mandatory microchipping laws in many countries apply specifically to dogs, and because dog ownership rates and veterinary visit frequency exceed those of other species. Cats are the fastest-growing segment as newly enacted mandates extend the same identification requirement to cats, prompting a wave of catch-up implantation among previously unchipped cat populations. The order does not change: Dogs is still largest in 2034, and what moves is how much it holds.
By End User · 3 segments
Veterinary Clinics & Hospitals Held the Dominant Share of the End user Segment in 2025
- Largest Veterinary Clinics & Hospitals · 64%
- Fastest Animal Shelters & Rescue Organizations · 8.9%
- Moves most Veterinary Clinics & Hospitals · -3 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Veterinary Clinics & Hospitals | $392M | 64% | $727M | 61%-3 | 7.1% |
| Animal Shelters & Rescue Organizations | $172M | 28% | $370M | 31%+3 | 8.9% |
| Breeders & Catteries/Kennels | $49M | 8% | $95.30M | 8% | 7.7% |
Veterinary clinics and hospitals lead because implantation is a clinical procedure usually performed during a routine visit, and clinics are the primary point of contact between pet owners and chip suppliers. Animal shelters and rescue organizations are growing fastest as municipal and welfare-driven bulk microchipping programs expand ahead of adoption, meeting mandatory identification requirements before an animal is rehomed. Veterinary Clinics & Hospitals remains the largest line through 2034, so the axis changes in proportion, not in order.
By Distribution Channel · 3 segments
Direct Sales Led by Distribution channel in 2025, with E-commerce/Online Growing Fastest
- Largest Direct Sales · 55%
- Fastest E-commerce/Online · 11.9%
- Moves most E-commerce/Online · +5 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Direct Sales | $337M | 55% | $620M | 52%-3 | 7% |
| Distributors & Wholesalers | $202M | 33% | $370M | 31%-2 | 6.9% |
| E-commerce/Online | $73.50M | 12% | $203M | 17%+5 | 11.9% |
Direct sales lead because large manufacturers maintain supply relationships directly with major veterinary clinic chains and national shelter networks, securing volume commitments that smaller channels cannot match. E-commerce is growing fastest as independent clinics, breeders and smaller shelters increasingly order chip and scanner kits online instead of through regional distributors, shortening procurement cycles. By 2034 Direct Sales is still ahead, making this a shift in weight, not a change of leader.
By Functionality · 2 segments
Bio-Sensor Enabled (Temperature-Sensing) Microchips Outpaces the Axis While Standard Identification Microchips Holds the Largest Share
- Largest Standard Identification Microchips · 90%
- Fastest Bio-Sensor Enabled (Temperature-Sensing) Microchips · 14.2%
- Moves most Standard Identification Microchips · -7 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Standard Identification Microchips | $551M | 90% | $989M | 83%-7 | 6.7% |
| Bio-Sensor Enabled (Temperature-Sensing) Microchips | $61.30M | 10% | $203M | 17%+7 | 14.2% |
Standard identification microchips lead because they satisfy the baseline legal identification requirement at the lowest cost per unit, which remains the primary purchase driver for shelters and municipal programs. Bio-sensor enabled microchips are growing fastest off a small base as veterinary clinics adopt temperature-sensing variants that add diagnostic value beyond identification alone, justifying a price premium. Standard Identification Microchips remains the largest line through 2034, so the axis changes in proportion, not in order.
Regional Insights
Regional Revenue Share
Base year 2025Share of global revenue in the base year.
Only the leading region's share is published outside the report; pins mark the region, not a specific country.
North America Market Analysis
The largest region covered — 4 points of share move elsewhere by 2034, while revenue still grows 1.7×.
- Rank 1 of 5
- 2025 share 38%
- By 2034 34%
- Revenue $233M → $405M
In North America, 38% of global revenue puts 2025 at USD 232.8 million on the way to USD 405.2 million by 2034. It is a dominant region on this axis, first by revenue throughout the period.
By 2034 the share stands at 34%, a shift in share, not in direction: revenue climbs every year while the market's centre of gravity moves elsewhere.
134.2 kHz Microchip leads here as it does globally, at 62% of 2025 revenue, and 134.2 kHz Microchip again grows fastest at 9.15%. The full report breaks North America out along every axis and by country.
United States
Sets the pace for North America at 85% of it, growing 1.7×.
- In region 1 of 2
- Of region 85%
- Of global 32.3%
- Revenue $198M → $344M
The United States is the largest market within North America, generating USD 197.9 million in 2025 and projected to reach USD 344.4 million by 2034. Carrying 85.01% of the region in the base year, it sets North America's direction instead of merely contributing to it. Against regional totals of USD 232.8 million in 2025 and USD 405.2 million in 2034, it is the country the full report breaks out in detail.
the United States buys along the same lines as the market globally; 134.2 kHz Microchip first at 62% of 2025 revenue and 70% in 2034, 134.2 kHz Microchip fastest at 9.15% on a share moving from 62% to 70%. Because the country carries 85.01% of North America, a movement in its own mix shows up in the regional totals instead of being averaged away by neighbouring markets. Revenue by type for the United States is reported separately in the full report.
Pet microchips sold in the United States are regulated by the Food and Drug Administration as veterinary medical devices, since implantation involves a physical device placed under an animal's skin. Manufacturers must meet the FDA's general device controls, including facility registration, product listing, and adherence to good manufacturing practice requirements for biocompatibility and sterility. Because microchips rely on radio frequency identification, suppliers must also ensure compliance with Federal Communications Commission rules governing the frequency bands used for transmission. Labelling must disclose the chip's frequency and confirm compatibility with standard scanners used by veterinarians and shelters. There is no federal mandate requiring implantation, so state and municipal rules vary, but any product marketed for animal identification must still satisfy these underlying device and radio-equipment standards before it reaches suppliers or veterinary clinics.
In the United States the field is Pethealth Inc., HomeAgain, Bayer, AVID Identification Systems, Datamars, Inc., Trovan, Ltd., Virbac, Animalcare, Ltd., Microchip4Solutions Inc., PeddyMark, EIDAP Inc., Micro-ID, Ltd. and Cybortra Technology.. One line leads on both counts here: 134.2 kHz Microchip holds 62% of 2025 revenue and compounds fastest at 9.15%. Country-level shares and positioning per company sit in the full report.
Canada
2nd-largest in North America, growing 1.7×.
- In region 2 of 2
- Of region 15%
- Of global 5.7%
- Revenue $34.90M → $60.80M
5.7% of global revenue is generated in Canada; USD 34.9 million in 2025, reaching USD 60.8 million in 2034, and 14.99% of North America.
Europe Market Analysis
The 2nd-largest region covered — 3 points of share move elsewhere by 2034, while revenue still grows 1.8×.
- Rank 2 of 5
- 2025 share 32%
- By 2034 29%
- Revenue $196M → $346M
In Europe, 32% of global revenue puts 2025 at USD 196 million and reaches USD 345.6 million by 2034. Among the five regions it ranks second by revenue in both years.
Share settles at 29% in 2034, while nothing contracts here; other regions simply grow faster, which shows up as relative weight, not as falling revenue.
Segment composition follows the global pattern: 134.2 kHz Microchip largest at 62% of 2025 revenue, 134.2 kHz Microchip fastest at 9.15%. Europe is reported axis by axis and country by country in the full study.
Germany
The largest market in Europe, growing 1.8×.
- In region 1 of 3
- Of region 30%
- Of global 9.6%
- Revenue $58.80M → $104M
Germany is the largest market within Europe, generating USD 58.8 million in 2025 and projected to reach USD 103.7 million by 2034. It accounts for 30% of regional revenue in the base year, the largest single share without dominating the region outright. Against regional totals of USD 196 million in 2025 and USD 345.6 million in 2034, it is the country the full report breaks out in detail.
Germany buys along the same lines as the market globally; 134.2 kHz Microchip first at 62% of 2025 revenue and 70% in 2034, 134.2 kHz Microchip fastest at 9.15% on a share moving from 62% to 70%. With 30% of Europe concentrated here, a change in this country's mix is visible in the regional figures instead of being diluted by its neighbours. Germany carries its own type breakdown in the full report.
In Germany, pet microchips fall under European Union veterinary and animal identification frameworks rather than the human Medical Devices Regulation, since the product is intended for animals. Suppliers must ensure chips conform to the ISO standards for radio frequency identification of animals, which the EU has adopted as the technical basis for interoperability between scanners and chips across member states. Manufacturers and importers must maintain technical documentation demonstrating conformity and affix labelling that identifies the chip as compliant with the relevant harmonised standard. Because microchips for companion animals are closely tied to EU pet travel and identification rules, suppliers must confirm the chip can be read by standard ISO-compliant scanners used by veterinarians and border authorities. German veterinary and animal welfare authorities oversee enforcement of correct implantation practice, while the technical conformity of the device itself is assessed against the harmonised RFID standard.
In Germany the field is Pethealth Inc., HomeAgain, Bayer, AVID Identification Systems, Datamars, Inc., Trovan, Ltd., Virbac, Animalcare, Ltd., Microchip4Solutions Inc., PeddyMark, EIDAP Inc., Micro-ID, Ltd. and Cybortra Technology.. Volume and growth sit in the same line, 134.2 kHz Microchip, at 62% of 2025 revenue and 9.15% growth. Weighting toward Europe means competing for 32% of 2025 global revenue, a base of USD 196 million moving to USD 345.6 million across the forecast period.
United Kingdom
2nd-largest in Europe, growing 1.8×.
- In region 2 of 3
- Of region 26%
- Of global 8.3%
- Revenue $51M → $93.30M
Within Europe, the United Kingdom accounts for 26.02% of regional revenue and 8.33% of the global total, worth USD 51 million in 2025 and USD 93.3 million by 2034.
France
3rd-largest in Europe, growing 1.8×.
- In region 3 of 3
- Of region 18%
- Of global 5.8%
- Revenue $35.30M → $62.20M
France is sized at USD 35.3 million in 2025, rising to USD 62.2 million by 2034; 5.76% of global revenue and 18.01% of Europe. It is reported separately from Germany across every segmentation axis in the full report.
Asia Pacific Market Analysis
The 3rd-largest region covered, and the one gaining the most — it picks up 6 points of share by 2034, while revenue still grows 2.5×.
- Rank 3 of 5
- 2025 share 20%
- By 2034 26%
- Revenue $123M → $310M
Asia Pacific holds 20% of the global pet microchips market in 2025, worth USD 122.5 million rising to USD 309.9 million in 2034. Among the five regions it ranks third by revenue in both years.
Share climbs to 26% by 2034, so the region grows faster than the market's 7.7% and takes a larger part of the revenue added by 2034 than its 2025 weight implies.
134.2 kHz Microchip leads here as it does globally, at 62% of 2025 revenue, and 134.2 kHz Microchip again grows fastest at 9.15%. Revenue for Asia Pacific is broken out by every segmentation axis and by country in the full report.
China
The largest market in Asia Pacific, growing 2.8×.
- In region 1 of 3
- Of region 32%
- Of global 6.4%
- Revenue $39.20M → $109M
China is the largest market within Asia Pacific, generating USD 39.2 million in 2025 and projected to reach USD 108.5 million by 2034. Its 32% of base-year regional revenue leads the region, though enough sits elsewhere that Asia Pacific is not a proxy for it. Set against USD 122.5 million and USD 309.9 million for the region, it is why this market, and not a smaller one, is the one reported in full.
China buys along the same lines as the market globally; 134.2 kHz Microchip first at 62% of 2025 revenue and 70% in 2034, 134.2 kHz Microchip fastest at 9.15% on a share moving from 62% to 70%. Its 32% weight in Asia Pacific means those movements carry straight into the regional totals. China carries its own type breakdown in the full report.
In China, pet microchips are regulated as veterinary instruments under the oversight of the Ministry of Agriculture and Rural Affairs, which governs products used in animal husbandry and companion animal management. Suppliers must obtain the applicable veterinary product registration before the device can be marketed, and manufacturing facilities are expected to meet quality management requirements analogous to those applied to other veterinary instruments. Because the chips are radio frequency devices, compliance with China's radio equipment type approval requirements, administered by the telecommunications regulator, is also required to confirm the operating frequency does not interfere with other licensed uses. Labelling must identify the product's intended use in companion animal identification and specify compatibility with scanning equipment used by veterinary clinics and local pet registration authorities, which increasingly require chip-based identification as part of municipal pet licensing programs.
In China the field is Pethealth Inc., HomeAgain, Bayer, AVID Identification Systems, Datamars, Inc., Trovan, Ltd., Virbac, Animalcare, Ltd., Microchip4Solutions Inc., PeddyMark, EIDAP Inc., Micro-ID, Ltd. and Cybortra Technology.. Volume and growth sit in the same line, 134.2 kHz Microchip, at 62% of 2025 revenue and 9.15% growth. The commercial size of that position is USD 122.5 million in 2025 and USD 309.9 million by 2034, 20% of the global total in the base year.
Japan
2nd-largest in Asia Pacific, growing 2.3×.
- In region 2 of 3
- Of region 24%
- Of global 4.8%
- Revenue $29.40M → $68.20M
Japan is sized at USD 29.4 million in 2025, rising to USD 68.2 million by 2034; 4.8% of global revenue and 24% of Asia Pacific. It is reported separately from China across every segmentation axis in the full report.
Australia
3rd-largest in Asia Pacific, growing 2.2×.
- In region 3 of 3
- Of region 18%
- Of global 3.6%
- Revenue $22.10M → $49.60M
3.61% of global revenue is generated in Australia; USD 22.1 million in 2025, reaching USD 49.6 million in 2034, and 18.04% of Asia Pacific.
Latin America Market Analysis
The 4th-largest region covered — it picks up 1 point of share by 2034, while revenue still grows 2.3×.
- Rank 4 of 5
- 2025 share 6%
- By 2034 7%
- Revenue $36.80M → $83.40M
Latin America holds 6% of the global pet microchips market in 2025, worth USD 36.8 million on the way to USD 83.4 million by 2034. By revenue it sits fourth across the study, and the ranking does not change between 2025 and 2034.
Its share rises to 7% over the forecast period, on growth above the market's own 7.7%, and with a bigger contribution to the revenue added over the period than the base-year figure suggests.
Segment composition follows the global pattern: 134.2 kHz Microchip largest at 62% of 2025 revenue, 134.2 kHz Microchip fastest at 9.15%. Latin America is reported axis by axis and country by country in the full study.
Brazil
The largest market in Latin America, growing 2.3×.
- In region 1 of 2
- Of region 54.9%
- Of global 3.3%
- Revenue $20.20M → $45.90M
Brazil is the largest market within Latin America, generating USD 20.2 million in 2025 and projected to reach USD 45.9 million by 2034. Its 54.89% of base-year regional revenue leads the region, though enough sits elsewhere that Latin America is not a proxy for it. The region itself runs USD 36.8 million to USD 83.4 million over the same period, and this is the market carrying the country-level detail in the full report.
The type pattern in Brazil is the global one: 62% of 2025 revenue in 134.2 kHz Microchip, 70% by 2034, against 9.15% growth in 134.2 kHz Microchip taking it from 62% to 70%. Its 54.89% weight in Latin America means those movements carry straight into the regional totals. Per-type revenue for Brazil appears on its own in the full report.
Brazil regulates pet microchips through the Ministry of Agriculture, Livestock and Supply, which oversees veterinary products and animal identification technologies under its animal health directorate. Suppliers must register the product as a veterinary instrument, demonstrating that the chip and its associated implantation applicator meet biocompatibility and sterility expectations before distribution to veterinary clinics. Because the device transmits over radio frequency, approval from Brazil's telecommunications regulator is also required to confirm the chip operates within permitted frequency allocations. Several Brazilian states and municipalities have adopted mandatory pet identification rules, so suppliers must ensure their chips are readable by the ISO-standard scanners typically used in these local registries. Labelling must state the chip's frequency and confirm its intended use for companion animal identification, allowing veterinarians to verify compatibility with existing scanning infrastructure before implantation.
Competition in Brazil runs between the suppliers this study tracks: Pethealth Inc., HomeAgain, Bayer, AVID Identification Systems, Datamars, Inc., Trovan, Ltd., Virbac, Animalcare, Ltd., Microchip4Solutions Inc., PeddyMark, EIDAP Inc., Micro-ID, Ltd. and Cybortra Technology.. 134.2 kHz Microchip is where the volume is, at 62% of 2025 revenue, and it is growing fastest as well at 9.15%. Weighting toward Latin America means competing for 6% of 2025 global revenue, a base of USD 36.8 million moving to USD 83.4 million across the forecast period.
Mexico
2nd-largest in Latin America, growing 2.3×.
- In region 2 of 2
- Of region 35%
- Of global 2.1%
- Revenue $12.90M → $29.20M
Mexico is sized at USD 12.9 million in 2025, rising to USD 29.2 million by 2034; 2.11% of global revenue and 35.05% of Latin America. It is reported separately from Brazil across every segmentation axis in the full report.
Middle East and Africa Market Analysis
The 5th-largest region covered, holding its share flat through 2034, while revenue still grows 1.9×.
- Rank 5 of 5
- 2025 share 4%
- By 2034 4%
- Revenue $24.50M → $47.70M
Middle East and Africa holds 4% of the global pet microchips market in 2025, worth USD 24.5 million rising to USD 47.7 million in 2034. That makes it the fifth-largest region covered, in 2025 and again in 2034.
4% of global revenue sits here in 2034, below the 2025 level, while nothing contracts here; other regions simply grow faster, which shows up as relative weight, not as falling revenue.
134.2 kHz Microchip leads here as it does globally, at 62% of 2025 revenue, and 134.2 kHz Microchip again grows fastest at 9.15%. Middle East and Africa is reported axis by axis and country by country in the full study.
South Africa
The largest market in Middle East and Africa, growing 1.8×.
- In region 1 of 2
- Of region 40%
- Of global 1.6%
- Revenue $9.80M → $18.10M
The largest single market in Middle East and Africa is South Africa, at USD 9.8 million in 2025 and USD 18.1 million in 2034. It accounts for 40% of regional revenue in the base year, the largest single share without dominating the region outright. Against regional totals of USD 24.5 million in 2025 and USD 47.7 million in 2034, it is the country the full report breaks out in detail.
Composition here matches the global split: the largest line is 134.2 kHz Microchip at 62% of 2025 revenue, easing to 70% by 2034, and the fastest is 134.2 kHz Microchip at 9.15%, from 62% to 70%. Since 40% of Middle East and Africa's revenue is generated here, the regional numbers inherit this market's mix instead of smoothing it out. Per-type revenue for South Africa appears on its own in the full report.
In South Africa, pet microchips are regulated as veterinary devices under the Department of Agriculture, Land Reform and Rural Development, acting through its veterinary services directorate, which governs products used in animal health and identification. Suppliers must register the chip as a veterinary instrument and demonstrate that it meets biocompatibility standards suitable for subcutaneous implantation in companion animals. Because the chips operate as radio frequency devices, type approval from South Africa's communications regulator is required to confirm the equipment meets permitted frequency and emission limits. The South African Veterinary Council sets professional standards for how microchips are implanted and recorded by registered veterinarians, and suppliers commonly align their products with ISO standards for animal identification so that chips remain compatible with the scanning equipment used by veterinary practices, shelters and national pet registries.
In South Africa the field is Pethealth Inc., HomeAgain, Bayer, AVID Identification Systems, Datamars, Inc., Trovan, Ltd., Virbac, Animalcare, Ltd., Microchip4Solutions Inc., PeddyMark, EIDAP Inc., Micro-ID, Ltd. and Cybortra Technology.. 134.2 kHz Microchip is both the largest line, at 62% of 2025 revenue, and the fastest-growing at 9.15%. The commercial size of that position is USD 24.5 million in 2025 and USD 47.7 million by 2034, 4% of the global total in the base year.
United Arab Emirates
2nd-largest in Middle East and Africa, growing 2.1×.
- In region 2 of 2
- Of region 30.2%
- Of global 1.2%
- Revenue $7.40M → $15.30M
Within Middle East and Africa, the United Arab Emirates accounts for 30.2% of regional revenue and 1.21% of the global total, worth USD 7.4 million in 2025 and USD 15.3 million by 2034.
Request this sample to see the full data tables and segment-level detail behind this analysis.
Report Coverage
This report assesses the market across every segment, with revenue and a growth rate for each line in each year of the study period. It covers the drivers, trends, opportunities, restraints and challenges shaping growth, the competitive landscape and the companies profiled, and the research methodology behind every estimate. Segmentation is reported by Type, Application, End User, Distribution Channel, Functionality, and regional analysis covers North America, Europe, Asia Pacific, Latin America, Middle East and Africa, each broken out by country.
Competitive Landscape
Suppliers Compete on 134.2 kHz Microchip Volume and 134.2 kHz Microchip Momentum
The suppliers covered are: Pethealth Inc., HomeAgain, Bayer, AVID Identification Systems, Datamars, Inc., Trovan, Ltd., Virbac, Animalcare, Ltd., Microchip4Solutions Inc., PeddyMark, EIDAP Inc., Micro-ID, Ltd. and Cybortra Technology..
The type axis, not the regional one, is where competition happens. Volume sits in 134.2 kHz Microchip, USD 379.8 million and 62% of 2025 revenue, 70% by 2034, which is also where an incumbent is hardest to dislodge. The line that changes hands is 134.2 kHz Microchip at 9.15%, well ahead of 125 kHz Microchip at 4.04%. The two rarely sit with the same supplier, and that is the reason a USD 612.6 million market is not already consolidated.
Suppliers differentiate on ISO-standard compliance and universal scanner compatibility, on manufacturing scale and unit-cost position, on established direct relationships with veterinary clinic chains and national pet registries, and on the depth of the registry and database infrastructure that keeps a chip's ownership record retrievable after implantation. Larger suppliers hold an advantage in direct clinic-chain contracts and integrated registry platforms that smaller or regional makers cannot easily replicate. Smaller and regional suppliers compete on price in cost-sensitive markets, on faster fulfillment through local distributors, and on partnerships with national shelter networks in their home geography, where a global supplier typically has less on-the-ground presence.
Presence matters unevenly by region. With 38% of 2025 revenue in North America and 32% in Europe, a supplier's coverage of those two decides most of its addressable base before any product question arises.
Profiles, financials, shares and development histories for each company sit in the full report; this summary carries the structure only.
List of Key Pet Microchips Market Companies Profiled
13 companies profiled. Company profiles, including financials, product portfolios and recent developments, are part of the full report.
- Pethealth Inc.(Canada)
- HomeAgain(United States)
- Bayer(Germany)
- AVID Identification Systems(United States)
- Datamars, Inc.(Switzerland)
- Trovan, Ltd.(United Kingdom)
- Virbac(France)
- Animalcare, Ltd.(United Kingdom)
- Microchip4Solutions Inc.
- PeddyMark(United Kingdom)
- EIDAP Inc.(Canada)
- Micro-ID, Ltd.(United Kingdom)
- Cybortra Technology.
Geographic Coverage
Every market below is broken out separately in the report.
North America
3Europe
8Asia Pacific
12Latin America
3Middle East and Africa
4Key Insights
Report Scope
Study parameters & segmentationThis study covers market size and forecasts over the 2020–2034 period, segmentation across 5 axes (Type, Application, End User, Distribution Channel, Functionality), regional analysis for 5 regions and their constituent countries, a competitive landscape profiling 13 key companies, and the research methodology behind every estimate.
Segmentation
5 axes + regionFull chapter-and-section structure of the report. Segment, region, and company breakdowns are listed as scope. The underlying figures are in the sample and full report.
Table of Contents+−
Chapter 1.Executive Summary
Chapter 2.Premium Insights
Chapter 3.Market Definition
Chapter 4.Research Methodology
Chapter 5.Strategic Imperatives & Market Outlook
Chapter 6.Go-to-Market (GTM) Strategies
Chapter 7.Market Trends, Strategy & Dynamics
Chapter 8.Porter's Five Forces
Chapter 9.PESTEL Analysis
Chapter 10.Value Chain Analysis
Chapter 11.Supply Chain Analysis
Chapter 12.Macro-Economic Factors
Chapter 13.Market Cost Analysis
Chapter 14.Market Supply-Side Analysis
Chapter 15.Global Pet Microchips Market Size & Projections, 2020–2034, Revenue (USD Million)
Chapter 16.Global Pet Microchips Market Overview, By Type, 2020–2034, Revenue (USD Million)
Chapter 17.Global Pet Microchips Market Overview, By Application, 2020–2034, Revenue (USD Million)
Chapter 18.Global Pet Microchips Market Overview, By End User, 2020–2034, Revenue (USD Million)
Chapter 19.Global Pet Microchips Market Overview, By Distribution Channel, 2020–2034, Revenue (USD Million)
Chapter 20.Global Pet Microchips Market Overview, By Functionality, 2020–2034, Revenue (USD Million)
Chapter 21.Global Pet Microchips Market Size — Segment Comparison
Chapter 22.Global Pet Microchips Geography Overview, 2020–2034, Revenue (USD Million)
Chapter 23.North America Pet Microchips Market Deep-Dive, 2020–2034, Revenue (USD Million)
Chapter 24.Europe Pet Microchips Market Deep-Dive, 2020–2034, Revenue (USD Million)
Chapter 25.Asia Pacific Pet Microchips Market Deep-Dive, 2020–2034, Revenue (USD Million)
Chapter 26.Latin America Pet Microchips Market Deep-Dive, 2020–2034, Revenue (USD Million)
Chapter 27.Middle East and Africa Pet Microchips Market Deep-Dive, 2020–2034, Revenue (USD Million)
Chapter 28.Application / Use-Case Analysis
Chapter 29.Vendor Capability Scorecard
Chapter 30.Scenario Forecasts
Chapter 31.Top 10 Key Clients of Top 10 Players
Chapter 32.Top 10 Suppliers
Chapter 33.Competitive Landscape
Chapter 34.Partnerships & M&A
Chapter 35.Key Vendor Analysis
Chapter 36.Marketing Strategy Analysis, Distributors & Traders
Chapter 37.Outlook of the Market
Chapter 38.Concluding Analyst Note
List of Figures+−
Structural index generated from this report's own section headings, not verified against the delivered report's actual figure numbering.
List of Tables+−
Structural index generated from this report's own section headings, not verified against the delivered report's actual table numbering.
Segmentation Analysis
5 axesBy Type
3- 01125 kHz Microchip
- 02128 kHz Microchip
- 03134.2 kHz Microchip
By Application
4- 01Dogs
- 02Cats
- 03Horse
- 04Others
By End User
3- 01Veterinary Clinics & Hospitals
- 02Animal Shelters & Rescue Organizations
- 03Breeders & Catteries/Kennels
By Distribution Channel
3- 01Direct Sales
- 02Distributors & Wholesalers
- 03E-commerce/Online
By Functionality
2- 01Standard Identification Microchips
- 02Bio-Sensor Enabled (Temperature-Sensing) Microchips
Segment categories shown for scope reference. See the Summary tab for revenue share by By Type. Full segment-by-segment detail across every axis is available in the sample and full report.
Research approach
A market size is a claim about the world, and a claim is only as good as the route to it. Every study is built upward from units and prices — what is actually produced, sold or performed, at what it actually changes hands for — rather than from a headline figure divided downwards. Disclosed company revenue is then used to check that build, not to produce it.
Build upward from unit volumes (annual number of dogs, cats and horses newly implanted, drawn from national and regional companion-animal population estimates and veterinary-visit frequency data) multiplied by realized per-unit pricing at each stage of the distribution chain: manufacturer, distributor and clinic. The bottom-up build is then checked against disclosed revenue and shipment figures reported by the identified microchip manufacturers in public filings or investor disclosures, and against national pet-registry enrollment counts where those registries publish annual figures. Where the two diverge, the correction is made to the underlying volume or price assumption in the bottom-up build, not by averaging the two figures together.
The four stages
The same sequence runs behind every published study, whatever the industry. The order matters as much as the steps: the segment axes are fixed before any number is collected, so the model is never reshaped to fit whatever data happens to turn up.
What the build rests on, and what checks it
The two are not interchangeable. The left column produces the number; the right column tests it. When the check disagrees with the build, the answer is to find which bottom-up assumption is wrong — a unit count, a price, a take-up rate — not to split the difference between them.
- Volume actually transacted — units produced, installed, dispensed or procedures performed, counted at the level each is genuinely recorded
- Realised pricing by tier and channel, rather than one blended average applied across the whole market
- Take-up and frequency: how much of the addressable base buys, and how often it repeats
- Disclosed revenue of the companies serving the market, where filings separate it far enough to be usable
- Buyer-side spending totals — capital budgets, procurement lines, or the output of the end market the product is bought against
- Trade and customs flows, where the product crosses borders in a separately recorded form
Data sources
Published data establishes what happened. Only the people transacting in a market can say why, and what is about to change — so the two are collected separately and weighted differently.
- Commercial and product leadership at the companies that supply the market
- Procurement and specification leads at the organisations that buy it
- Distributors, integrators and channel partners, where the market is served indirectly
- Regulatory and standards specialists, where approval governs what can be sold at all
- Company filings, annual reports and investor disclosure
- Government statistics, customs records and regulatory registers
- Trade association output and standards-body publications
- Technical and peer-reviewed literature, where the market rests on a clinical or engineering claim
Interviews target procurement and clinical staff at veterinary clinic groups and shelter networks, regulatory affairs contacts at national pet-registry operators, purchasing managers at microchip distributors, and compliance staff at animal-welfare organizations that run bulk implantation programs, since these roles collectively set purchase volumes, chip-format decisions and end-user pricing. Geographic sampling weights North America and Europe, where mandatory identification programs already generate high procedure volume and where registry participation is easiest to verify, with additional coverage in Australia and East Asia, where mandates and pet ownership are both expanding and where the frequency-format mix is still shifting toward the ISO standard.
Desk research draws on national pet-registry enrollment statistics such as PetLink, Found Animals and the equivalent national databases operated across the EU and UK, ISO 11784/11785 standard-compliance documentation used to distinguish frequency formats, veterinary association benchmark surveys on annual procedure volumes, customs and trade classification data covering implantable RFID transponders, and public company filings from the identified microchip manufacturers where such filings are available. Government animal-welfare agency reports on shelter intake and adoption volumes supplement these sources in the jurisdictions where mandatory microchipping before rehoming is already in effect.
Desk research runs across proprietary research databases including Factiva, OneSource and Hoovers alongside the public sources above. Modelling and statistical validation are run in SAS and SPSS.
Forecasting
The forecast is not a growth rate applied to a base year. It is built from the drivers that are expected to change, each one stated so a reader can disagree with it.
The forecast is built from projected companion-animal population growth by region, the pace at which remaining jurisdictions adopt mandatory microchipping for dogs and cats, and the rate at which the legacy 125 kHz and 128 kHz installed base converts to the ISO-standard 134.2 kHz format. Pricing is held broadly flat in real terms, consistent with the limited historical movement in per-unit chip pricing. The forecast assumes no reversal of existing mandates and normalizes for the temporary surge in shelter adoption activity that typically follows mandate enactment in a given jurisdiction, treating that surge as a one-time step, not a sustained growth rate.
Triangulation and validation
No figure enters a report on the strength of one source. Where the two sizing routes disagree the difference is not averaged away — the assumption causing it is isolated, tested against a third independent measure, and either corrected or carried forward as a stated limitation. Historical years are back-tested against the growth actually recorded before any forecast is allowed to run forward from them.
Outputs were back-tested against recorded 2020-2024 growth in the markets with the longest-standing mandates, to confirm the assumed post-mandate growth curve is consistent with observed history. Segment-level shifts in frequency-format mix and end-user mix were reviewed against the pace of scanner-fleet replacement reported by veterinary equipment suppliers. Sensitivities were tested on the pace of new-mandate adoption and on shelter-program funding levels, since both move procedure volume independently of underlying pet population growth. Outputs were also compared against the frequency-format mix reported in national registry statistics for the two markets where that split is publicly disclosed, to confirm the modeled conversion pace toward the ISO standard is not overstated.
Confidence and limitations
Where an estimate is firm and where it is not is stated rather than left to be inferred from the precision of the number.
The frequency-format and regional splits are the firmest part of this estimate, anchored to standard-compliance and national registry data that is reported consistently across the markets studied. The end-user and distribution-channel splits are comparatively thinner, since neither is reported directly by any single source and both are triangulated from clinic and distributor purchasing patterns. A structural risk to the estimate is a jurisdiction delaying or reversing a planned mandate, which would lower shelter and clinic procurement faster than underlying pet population growth alone would suggest.
Every report purchase includes direct access to the lead analyst for scoping questions on the data, at no extra cost and with no separate booking process.
Request a tailored breakdown by geography, segment, or competitor set beyond what's in the standard report.
Questions This Report Answers
6 questionsWhat is the market size and growth rate, globally and by region?
How is the market segmented, and which segments lead?
Which regions and countries are covered, and how do they compare?
What are the key drivers, restraints, opportunities and challenges?
Who are the leading companies operating in this market?
What trends are expected to shape the market through the forecast period?
Frequently Asked Questions
01What is the Pet Microchips Market projected to reach?
USD 1191.8 Million by 2034, CAGR 7.7%
02What years does this report cover?
Study period 2020–2034, base year 2025, historical data 2020-2024, forecast period 2026-2034.
03Which regions are covered?
North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
04Which region accounted for the largest market share?
North America leads with 38% of global revenue through 2034.
05Which segment leads the market?
134.2 kHz Microchip is the largest line by Type, at 62% of revenue in 2025.
06Who are the key companies profiled?
Pethealth Inc., HomeAgain, Bayer, AVID Identification Systems, Datamars, Inc., Trovan, Ltd., Virbac, Animalcare, Ltd., Microchip4Solutions Inc., PeddyMark, EIDAP Inc., Micro-ID, Ltd., Cybortra Technology.. Full profiles are part of the paid report.
07Can the segmentation be customized?
Yes. Custom data cuts by geography, segment, or competitor set are available on request.
Why choose CDI
Need this report shaped around your question?
The scope isn't fixed. Tell us what your team needs that the standard edition doesn't cover, and an analyst will come back on what can be adjusted and how long it takes, before you commit to anything.
Most licences include 30–60 hours of customization at no extra cost. See what each licence includes
Additional Companies
Add competitors, suppliers or the peer set you benchmark against to the companies already covered.
Deeper Competitive View
Sharpen the landscape work around your own position: product line, channel, or a named shortlist of rivals.
Extra Segment Splits
Break the market down along an axis the standard scope doesn't cut it by, or go a level deeper inside one.
Application Focus
Narrow the analysis to the specific use cases and end users your team actually sells into.
Different Time Frame
Move the base year, or widen the historical and forecast windows the study is built on.
Country-Level Detail
Go below region level into the individual countries that matter to you, rather than the standard geography split.